Nadecnemab is an IgG4kappa antibody targeting to GFRA3, glial cell derived neurotrophic factor family receptor alpha 3. Nadecnemab can be used for research of osteoarthritis of the knee/pain[1].
Molecular Weight:
(144.86 kDa)
Purity:
95.00
CAS Number:
[2377679-19-9]
Target:
TGF-beta Receptor
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted